top of page

ViAqua Therapeutics Ltd.
About Us
ViAqua Therapeutics addresses the growing need for effective and affordable health management solutions for aquaculture. ViAqua’s 1st product is a novel oral delivery platform designed to deliver RNA. Co-developed with Skretting (a Nutreco company), RNA induced resistance to White Spot Shrimp Virus is incorporated into and delivered by shrimp-feed.

Sector:
Shellfish
Year Founded:
2014
Investment Stage:
Seed
bottom of page
